Development and reproducibility of a novel high-performance liquid-chromatography monolithic column method for the detection and quantification of trans-indolyl-3-acryloylglycine in human urine

Biomedical Chromatography

Volumn 23, Issue 10, 2009, Pages 1108-1115

  Carr, Kevin ^a   Whiteley, Paul ^a   Shattock, Paul ^a,b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b European Society for People with Autism   (United Kingdom)

Author keywords

Autism; High performance liquid chromatography; Indole; Mass spectrometry; Monolithic column; Tryptophan; Urine

Indexed keywords

AMINO ACIDS; BODY FLUIDS; COLUMN CHROMATOGRAPHY; DISEASES; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; SILICA;

AUTISM; DETECTION AND QUANTIFICATIONS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; INDOLE; MONOLITHIC COLUMNS; PERVASIVE DEVELOPMENTAL DISORDERS; REPRODUCIBILITIES; SOLID-PHASE EXTRACTION; TRYPTOPHAN; URINE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

INDOLE DERIVATIVE; INDOLYL 3 ACRYLOYLGLYCINE; UNCLASSIFIED DRUG;

AMINO ACID URINE LEVEL; ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MASS SPECTROMETRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; ULTRAVIOLET RADIATION; URINALYSIS; VALIDATION STUDY;

EID: 70549111154     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1231     Document Type: Article

References (16)

1. Alcorn A, Berney T, Bretherton K, Mills M, Savery D and Shattock P. Urinary compounds in autism. Journal of Intellect Disability Research 2004; 48: 274-278.
2. Anderson RJ, Bendell DJ, Garnett I, Groundwater PW, Lough WJ, Mills MJ, Savery D and Shattock PE. Identification of indolyl-3-acryloylglycine in the urine of people with autism. Journal of Pharmacy and Pharmacology 2002; 54: 295-298. (Pubitemid 34150066)
3. Asperger H. Die autistischen Psychopathen. Kindesalter Archiv für Psychiatrie und Nervenkrankheiten 1944; 117: 76-136.
4. Bull G, Shattock P, Whiteley P, Anderson R, Groundwater PW, Lough WJ and Lees G. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders. Medical Science Monitoring 2003; 9: CR2-CR5. (Pubitemid 37305252)
5. Jepson JB. In The Metabolic Basis of Inherited Disease, 2nd edn, Stanbury JB, Wyngaarden JB and Frederickson DS (eds). McGraw-Hill: New York, 1965; 1283-1299.
6. Kanner L. Autistic disturbances of affective contact. Nervous Children 1943; 2: 217-250.
7. Marklova E. Where does indolylacrylic acid come from? Amino Acids 1999; 17: 401-413. (Pubitemid 30025829)
8. Marklova E, Malina L and Hais IM. Urinary excretion of indolyl-3-acryloylglycine in some skin affections. Clinica Chimica Acta 1975; 64: 273-280.
9. Mills MJ, Savery D and Shattock PEG. Rapid analysis of low levels of indolyl-3-acryloylglycine in human urine by high-performance liquid chromatography. Journal of Chromatography B 1998; 712: 51-58. (Pubitemid 28322421)
10. Novakova L, Matysova L, Solichova M, Koupparis MA and Soliich P. Comparison of performance of C18 monolithic rod columns and conventional C18 particle-packed columns in liquid chromatographic determination of Estrogel and Ketoprofen gel. Journal of Chromatography B 2004; 813: 191-197. (Pubitemid 39535446)
11. Shattock P and Whiteley P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets 2002; 6: 175-183. (Pubitemid 34477460)
12. Solaas KM, Skjeldal O, Gardner MLG, Kase BF and Reichelt KL. Urinary peptides in Rett syndrome. Autism 2002; 6: 315-329.
13. Whiteley P, Rodgers J, Savery D and Shattock P. A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism 1999; 3: 45-65. (Pubitemid 29132473)
14. Whiteley P and Shattock P. What makes trans-indolyl-3-acrloylglycine (IAcrGly) identified by high-performance liquid-chromatography (HPLC) relevant to pervasive developmental disorders? Journal of Nutrition and Environmental Medicine 2003; 13: 1-7. (Pubitemid 38134768)
15. Whiteley P, Waring R, Williams L, Klovrza L, Nolan F, Smith S, Farrow M, Dodou K, Lough WJ and Shattock P. Spot urinary creatinine excretion in pervasive developmental disorders. Pediatrics International 2006; 48: 292-297. (Pubitemid 43752294)
16. World Health Organization. Tenth Revision of the International Classification of Diseases and Related Health Problems. Clinical Descriptions and Diagnostic Guidelines. WHO: Geneva, 1992.